Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma*

Background: MicroRNA-138 deregulation is a common event in cancer. Results: Our study describes a microRNA regulatory module consisting of tumor suppressor miR-138 and proto-oncogene FOSL1. Conclusion: The deregulation of miR-138-FOSL1 regulatory module may play an important role in cancer initiation and progression. Significance: Our results suggest that microRNAs target both canonical and non-canonical targeting sites located in all areas of mRNA molecules. MicroRNA-138 is one of the most frequently down-regulated microRNAs in cancer. We recently identified 51 candidate targets of microRNA-138 (Jiang, L., Dai, Y., Liu, X., Wang, C., Wang, A., Chen, Z., Heidbreder, C. E., Kolokythas, A., and Zhou, X. (2011) Hum. Genet. 129, 189–197). Among these candidates, Fos-like antigen 1 (FOSL1) is a member of Fos gene family and is a known proto-oncogene. In this study, we first confirmed the microRNA-138-mediated down-regulation of FOSL1 in squamous cell carcinoma cell lines. We then demonstrated the effect of this microRNA-138-FOSL1 regulatory module on downstream genes (homolog of Snail 2 (Snai2) expression and the Snai2-mediated repression of E-cadherin expression), as well as its contributions to tumorigenesis. The microRNA-138-directed recruitment of FOSL1 mRNA to the RNAi-induced silencing complex was confirmed by a ribonucleoprotein-immunoprecipitation assay. Three canonical and three high affinity non-canonical microRNA-138 (miR-138) targeting sites were identified on the FOSL1 mRNA: one in the 5′-UTR, three overlapping sites in the coding sequences, and two overlapping sites in the 3′-UTR. The direct targeting of miR-138 to these sites was confirmed using luciferase reporter gene assays. In summary, we describe an important microRNA regulatory module, which may play an important role in cancer initiation and progression. Our results also provide evidence that microRNAs target both canonical and non-canonical targeting sites located in all areas of the mRNA molecule (e.g. 5′-UTR, coding sequences, and 3′-UTR).

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[3]  T. Garland,et al.  Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma , 2011, Human Genetics.

[4]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[5]  R. Maestro,et al.  Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. , 1998, British Journal of Cancer.

[6]  M. Nikiforova,et al.  MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma , 2011, Annals of Surgical Oncology.

[7]  N. Gale,et al.  Cervical metastases of head and neck squamous cell carcinoma correlate with loss of heterozygosity on chromosome 16q. , 1999, International journal of oncology.

[8]  Lu Jiang,et al.  MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. , 2009, Cancer letters.

[9]  Lei Huang,et al.  Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma , 2012, International journal of cancer.

[10]  A. Schetter,et al.  MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.

[11]  Shuang Huang,et al.  Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. , 2009, Cancer research.

[12]  M. Hentze,et al.  Mechanism of translational regulation by miR-2 from sites in the 5' untranslated region or the open reading frame. , 2010, RNA.

[13]  Li Mao,et al.  Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. , 2006, Neoplasia.

[14]  A. Kolokythas,et al.  Downregulation of the Rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma , 2010, International journal of cancer.

[15]  G. Obernosterer,et al.  Post-transcriptional regulation of microRNA expression. , 2006, RNA.

[16]  B. Berger,et al.  Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. , 2011, Genome research.

[17]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[18]  Li Jin,et al.  miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells , 2010, PloS one.

[19]  P. S. Mitchell,et al.  MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression , 2011, Molecular Cancer Research.

[20]  Yi Jin,et al.  MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. , 2011, The Biochemical journal.

[21]  Xiaohong Zhao,et al.  miR-138 might reverse multidrug resistance of leukemia cells. , 2010, Leukemia research.

[22]  G. Wakabayashi,et al.  Downregulation of miR‐138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines , 2008, Cancer science.

[23]  R. Weichselbaum,et al.  Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. , 2002, European journal of cancer.

[24]  Hua Lu,et al.  Autoregulatory Suppression of c-Myc by miR-185-3p* , 2011, The Journal of Biological Chemistry.

[25]  A. Kolokythas,et al.  MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. , 2010, The Biochemical journal.

[26]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[27]  Wei Liu,et al.  Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP) , 2011, Experimental lung research.

[28]  Daniel Herschlag,et al.  Systematic Identification of mRNAs Recruited to Argonaute 2 by Specific microRNAs and Corresponding Changes in Transcript Abundance , 2008, PloS one.

[29]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[30]  J. Steitz,et al.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  Yukio Nakamura,et al.  Chondrocyte-Specific MicroRNA-140 Regulates Endochondral Bone Development and Targets Dnpep To Modulate Bone Morphogenetic Protein Signaling , 2011, Molecular and Cellular Biology.